









市场行情
/
股票
/
nasdaq-rvty
/

Revvity Inc

RVTY

96.200USD

-0.060-0.06%

收盘 12/19, 16:00（美东）报价延迟15分钟

10.97B总市值

48.35市盈率 TTM



Revvity Inc

96.200

-0.060-0.06%

概览公司财务分析

概览

公司

财务

分析

关于 Revvity Inc 公司

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

Revvity Inc简介



公司代码RVTY

公司名称Revvity Inc

上市日期Aug 12, 2101

CEOSingh (Prahlad R)

员工数量11000

证券类型Ordinary Share

年结日Aug 12

公司地址77 4Th Avenue

城市WALTHAM

上市交易所NASDAQ OMX NASDAQ Basic NYSE

国家United States of America

邮编02451

电话17816636900

网址https://www.revvity.com/

公司代码RVTY

上市日期Aug 12, 2101

CEOSingh (Prahlad R)

Revvity Inc公司高管



名称

名称/职务

职务

持股

持股变动

Dr. Prahlad R. Singh, Ph.D.

President, Chief Executive Officer, Director

96.84K

-8.87%

Mr. Alexandros P. (Alexis) Michas

Independent Non-Executive Chairman of the Board

45.44K

+6.67%

Mr. Joel S. Goldberg

Senior Vice President - Administration, General Counsel, Secretary

37.69K

+12.84%

Dr. Peter Barrett, Ph.D.

Independent Director

26.01K

+10.22%

Mr. Maxwell Krakowiak

Chief Financial Officer, Senior Vice President

22.80K

-2.39%

Ms. Miriame Victor

Chief Commercial Officer, Senior Vice President

14.29K

+61.74%

Ms. Pascale Witz

Independent Director

13.71K

+21.36%

Mr. Tajinder S. Vohra

Senior Vice President - Global Operations

10.44K

-53.85%

Mr. Michael A. Klobuchar

Independent Director

5.09K

+90.13%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

5.09K

+90.13%

名称

名称/职务

职务

持股

持股变动

Dr. Prahlad R. Singh, Ph.D.

President, Chief Executive Officer, Director

96.84K

-8.87%

Mr. Alexandros P. (Alexis) Michas

Independent Non-Executive Chairman of the Board

45.44K

+6.67%

Mr. Joel S. Goldberg

Senior Vice President - Administration, General Counsel, Secretary

37.69K

+12.84%

Dr. Peter Barrett, Ph.D.

Independent Director

26.01K

+10.22%

Mr. Maxwell Krakowiak

Chief Financial Officer, Senior Vice President

22.80K

-2.39%

Ms. Miriame Victor

Chief Commercial Officer, Senior Vice President

14.29K

+61.74%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Product

610.70M

84.79%

Service

109.58M

15.21%

地区USD

名称

营收

占比

Americas

323.58M

44.92%

Europe

203.63M

28.27%

Asia

193.07M

26.80%

业务

地区

业务USD

名称

营收

占比

Product

610.70M

84.79%

Service

109.58M

15.21%

股东统计

更新时间: 11月17日周一

持股股东

股东类型

持股股东

占比

T. Rowe Price Investment Management, Inc.

19.85%

The Vanguard Group, Inc.

11.88%

EdgePoint Investment Group Inc.

7.56%

T. Rowe Price Associates, Inc.

7.05%

Janus Henderson Investors

6.73%

其他

46.93%

持股股东

占比

T. Rowe Price Investment Management, Inc.

19.85%

The Vanguard Group, Inc.

11.88%

EdgePoint Investment Group Inc.

7.56%

T. Rowe Price Associates, Inc.

7.05%

Janus Henderson Investors

6.73%

其他

46.93%

股东类型

持股股东

占比

Investment Advisor

70.04%

Investment Advisor/Hedge Fund

25.98%

Hedge Fund

2.79%

Pension Fund

1.77%

Research Firm

1.69%

Sovereign Wealth Fund

1.18%

Bank and Trust

1.07%

Individual Investor

0.30%

Family Office

0.05%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

1177

117.06M

100.85%

-8.83M

2025Q2

1199

113.79M

98.03%

-7.04M

2025Q1

1255

117.73M

99.83%

-3.82M

2024Q4

1277

114.54M

95.28%

-3.97M

2024Q3

1253

112.35M

91.11%

-5.77M

2024Q2

1249

112.44M

91.13%

-1.63M

2024Q1

1287

107.57M

87.09%

-8.24M

2023Q4

1315

109.29M

88.55%

-2.41M

2023Q3

1347

106.10M

85.47%

-6.10M

2023Q2

1383

106.88M

85.21%

-9.65M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

T. Rowe Price Investment Management, Inc.

22.64M

19.51%

+126.19K

+0.56%

Jun 30, 2025

The Vanguard Group, Inc.

14.03M

12.09%

-297.65K

-2.08%

Jun 30, 2025

EdgePoint Investment Group Inc.

6.79M

5.85%

+1.43M

+26.65%

Jun 30, 2025

T. Rowe Price Associates, Inc.

7.80M

6.72%

-1.59M

-16.90%

Jun 30, 2025

Janus Henderson Investors

7.22M

6.22%

+1.23M

+20.47%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

5.81M

-259.62K

-4.28%

Jun 30, 2025

State Street Investment Management (US)

5.02M

4.32%

-150.58K

-2.91%

Jun 30, 2025

Geode Capital Management, L.L.C.

2.98M

2.56%

-18.52K

-0.62%

Jun 30, 2025

Invesco Capital Management LLC

1.94M

1.67%

+422.41K

+27.88%

Jun 30, 2025

UBS Financial Services, Inc.

1.75M

1.51%

+1.12M

+178.25%

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

First Trust Indxx Medical Devices ETF

2.12%

Invesco S&P 500 Equal Weight Health Care ETF

1.85%

T Rowe Price Capital Appreciation Equity ETF

1.36%

Simplify Health Care ETF

1.29%

ROBO Global Healthcare Technology & Innovation ETF

1.16%

First Trust Health Care Alphadex Fund

0.93%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

0.84%

VanEck Morningstar SMID Moat ETF

0.64%

Neuberger Berman Small-Mid Cap ETF

0.56%

NYLI Candriam US Mid Cap Equity ETF

0.5%

First Trust Indxx Medical Devices ETF

占比2.12%

Invesco S&P 500 Equal Weight Health Care ETF

占比1.85%

T Rowe Price Capital Appreciation Equity ETF

占比1.36%

Simplify Health Care ETF

占比1.29%

ROBO Global Healthcare Technology & Innovation ETF

占比1.16%

First Trust Health Care Alphadex Fund

占比0.93%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

占比0.84%

VanEck Morningstar SMID Moat ETF

占比0.64%

Neuberger Berman Small-Mid Cap ETF

占比0.56%

NYLI Candriam US Mid Cap Equity ETF

占比0.5%

分红派息



近5年累计派现 168.35M 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

Oct 23, 2025

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 06, 2026 going ex on Jan 16, 2026

Jan 16, 2026

Feb 06, 2026

Jan 16, 2026

Jul 24, 2025

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Nov 07, 2025 going ex on Oct 17, 2025

Oct 17, 2025

Nov 07, 2025

Oct 17, 2025

Apr 24, 2025

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 08, 2025 going ex on Jul 18, 2025

Jul 18, 2025

Aug 08, 2025

Jul 18, 2025

Jan 23, 2025

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 09, 2025 going ex on Apr 17, 2025

Apr 18, 2025

May 09, 2025

Apr 17, 2025

Oct 24, 2024

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025

Jan 17, 2025

Feb 07, 2025

Jan 17, 2025

Jul 25, 2024

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024

Oct 18, 2024

Nov 08, 2024

Oct 18, 2024

Apr 25, 2024

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024

Jul 19, 2024

Aug 09, 2024

Jul 19, 2024

Jan 25, 2024

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024

Apr 19, 2024

May 10, 2024

Apr 18, 2024

Oct 26, 2023

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024

Jan 19, 2024

Feb 09, 2024

Jan 18, 2024

Jul 21, 2023

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023

Oct 20, 2023

Nov 10, 2023

Oct 19, 2023

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Revvity Inc的前五大股东是谁？



Revvity Inc 的前五大股东如下：
T. Rowe Price Investment Management, Inc.持有股份：22.64M，占总股份比例：19.51%。
The Vanguard Group, Inc.持有股份：14.03M，占总股份比例：12.09%。
EdgePoint Investment Group Inc.持有股份：6.79M，占总股份比例：5.85%。
T. Rowe Price Associates, Inc.持有股份：7.80M，占总股份比例：6.72%。
Janus Henderson Investors持有股份：7.22M，占总股份比例：6.22%。